Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CATX NASDAQ:NTRB NASDAQ:OM NASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCATXPerspective Therapeutics$3.48+3.0%$3.74$1.60▼$16.02$258.44M1.2916,648 shs805,874 shsNTRBNutriband$7.15+3.2%$7.15$3.72▼$11.78$83.40M1.1332,104 shs18,318 shsOMOutset Medical$13.69-3.3%$15.53$5.85▼$25.35$251.39M2.13156,703 shs94,858 shsSKINBeauty Health$2.53+2.4%$1.98$0.78▼$2.56$313.26M1.23813,706 shs1.63 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCATXPerspective Therapeutics+2.96%+0.58%-8.66%+9.78%-77.76%NTRBNutriband+3.17%+12.07%+7.36%0.00%+86.20%OMOutset Medical-3.25%-2.28%+3.63%-31.41%+78.95%SKINBeauty Health+2.43%+23.41%+6.30%+65.36%+76.92%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCATXPerspective Therapeutics$3.48+3.0%$3.74$1.60▼$16.02$258.44M1.2916,648 shs805,874 shsNTRBNutriband$7.15+3.2%$7.15$3.72▼$11.78$83.40M1.1332,104 shs18,318 shsOMOutset Medical$13.69-3.3%$15.53$5.85▼$25.35$251.39M2.13156,703 shs94,858 shsSKINBeauty Health$2.53+2.4%$1.98$0.78▼$2.56$313.26M1.23813,706 shs1.63 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCATXPerspective Therapeutics+2.96%+0.58%-8.66%+9.78%-77.76%NTRBNutriband+3.17%+12.07%+7.36%0.00%+86.20%OMOutset Medical-3.25%-2.28%+3.63%-31.41%+78.95%SKINBeauty Health+2.43%+23.41%+6.30%+65.36%+76.92%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCATXPerspective Therapeutics 3.18Buy$12.56260.79% UpsideNTRBNutriband 3.00Buy$13.0081.82% UpsideOMOutset Medical 3.00Buy$24.6780.18% UpsideSKINBeauty Health 2.00Hold$2.633.75% UpsideCurrent Analyst Ratings BreakdownLatest NTRB, SKIN, CATX, and OM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/19/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSector Perform$22.008/7/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$21.00 ➝ $22.008/1/2025SKINBeauty HealthStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$3.00 ➝ $4.007/14/2025OMOutset MedicalBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$37.007/12/2025CATXPerspective TherapeuticsLifesci CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy6/23/2025CATXPerspective TherapeuticsB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$9.00 ➝ $12.006/23/2025CATXPerspective TherapeuticsWedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$11.00(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCATXPerspective TherapeuticsN/AN/AN/AN/A$2.67 per shareN/ANTRBNutriband$2.14M40.19N/AN/A$0.71 per share10.07OMOutset Medical$113.69M2.14N/AN/A$7.49 per share1.83SKINBeauty Health$334.30M0.96$0.06 per share39.06$0.41 per share6.17Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCATXPerspective Therapeutics-$46.51MN/A0.00N/AN/A-4,096.66%-27.40%-23.16%11/11/2025 (Estimated)NTRBNutriband-$10.48M-$2.87N/AN/AN/A-398.29%-85.40%-73.45%N/AOMOutset Medical-$127.98M-$20.29N/A∞N/A-82.06%-97.17%-32.84%11/5/2025 (Estimated)SKINBeauty Health-$29.10M-$0.28N/AN/AN/A-6.13%-32.82%-2.96%11/11/2025 (Estimated)Latest NTRB, SKIN, CATX, and OM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/9/2025Q2 2026NTRBNutriband-$0.17-$2.12-$1.95-$2.12$0.71 million$0.62 million8/7/2025Q2 2025SKINBeauty Health-$0.06$0.03+$0.09$0.03$74.67 million$78.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCATXPerspective TherapeuticsN/AN/AN/AN/AN/ANTRBNutribandN/AN/AN/AN/AN/AOMOutset MedicalN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCATXPerspective TherapeuticsN/A9.609.60NTRBNutriband0.014.783.48OMOutset Medical0.637.476.05SKINBeauty Health4.915.154.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCATXPerspective Therapeutics54.66%NTRBNutriband19.70%OMOutset MedicalN/ASKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipCATXPerspective Therapeutics3.72%NTRBNutriband54.09%OMOutset Medical2.40%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCATXPerspective Therapeutics7074.26 million65.21 millionOptionableNTRBNutriband1012.03 million5.53 millionNot OptionableOMOutset Medical52017.77 million17.34 millionNot OptionableSKINBeauty Health1,030126.82 million74.83 millionOptionableNTRB, SKIN, CATX, and OM HeadlinesRecent News About These CompaniesJacobs Levy Equity Management Inc. Sells 671,987 Shares of The Beauty Health Company $SKIN2 hours ago | marketbeat.comWhy your skin barrier might just be your most important beauty feature5 hours ago | msn.comBeauty sleep isn’t a myth – a sleep medicine expert explains how rest keeps your skin healthy and youthfulSeptember 12 at 10:57 AM | sfgate.comHerbal beauty expert Shahnaz Husain shares top 7 anti ageing face masks for younger looking skin: Banana, lemon, matchaSeptember 11 at 11:15 AM | msn.comHow smoking affects the skin: 16 side effects and risks you should knowSeptember 11 at 2:09 AM | timesofindia.indiatimes.comWhy BeautyHealth (SKIN) Stock Is Trading Lower TodaySeptember 10 at 3:06 PM | msn.comMichelle Monaghan, 49, on Skincare, Makeup Trailer Hacks, and the Beauty of AgingSeptember 10 at 2:25 AM | msn.comA Hydrating Toner Is My Beauty Editor Secret to Ridiculously Glowy Skin—And Most People Skip ItSeptember 9, 2025 | msn.comBeyond the 10-Step Routine: The Real Korean Beauty Secrets for Flawless SkinSeptember 9, 2025 | msn.comGlass Skin 2.0: Korean Beauty Trend for Radiant Skin in 2025September 9, 2025 | msn.comHealth Y Sol Brings Back the Ancient Art of Tallow Soap for Healthy SkinSeptember 9, 2025 | miamiherald.comMMULTIMEDIA UPDATE -- Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and GrowthSeptember 9, 2025 | globenewswire.comThe Beauty Health Company Launches Hydrafacial Advisory Councils and Ambassador Network to Enhance Provider Engagement and InnovationSeptember 9, 2025 | quiverquant.comQHydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and GrowthSeptember 9, 2025 | globenewswire.comMarie Claire UK Skin Awards 2025: Meet the Visionary Judges Defining the Best in BeautySeptember 8, 2025 | msn.comFrom Kitchen To Skincare: 10 Herbs And Spices That Naturally Enhance Skin Health And BeautySeptember 7, 2025 | msn.comSkin care Guide: 4 Step by Step DIY Face Packs for Glowing SkinSeptember 7, 2025 | msn.comMiranda Kerr reveals the at-home health hack she swears by and her ‘most underrated beauty secret’September 6, 2025 | msn.comSkin care guide: Rice Flour and Flax Seeds Face Mask For Natural Glowing SkinSeptember 5, 2025 | msn.comWhat Is an Egg-White Face Mask, and Can It Boost Skin Health?September 4, 2025 | everydayhealth.comEBeauty Health Modifies Indenture for Convertible NotesSeptember 4, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNTRB, SKIN, CATX, and OM Company DescriptionsPerspective Therapeutics NYSE:CATX$3.48 +0.10 (+2.96%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$3.44 -0.04 (-1.03%) As of 09/12/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company discovers, designs, and develop its initial programs candidates consists of VMT-a-NET, that is currently in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta-emitting therapy; and VMT01, which is currently in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma. Perspective Therapeutics, Inc. has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is headquartered in Seattle, Washington.Nutriband NASDAQ:NTRB$7.15 +0.22 (+3.17%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$7.02 -0.14 (-1.89%) As of 09/12/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Outset Medical NASDAQ:OM$13.69 -0.46 (-3.25%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$13.68 0.00 (-0.04%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Beauty Health NASDAQ:SKIN$2.53 +0.06 (+2.43%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.52 -0.01 (-0.59%) As of 09/12/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Broadcom Gets Big Upgrades: How High Analysts See Shares Going Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
